Nanoparticles (NPs) may cause cell and tissue damage, leading to local and systemic inflammatory responses and adverse effects on health due to the inhalation of particulate matter. The inflammasome is a major regulator of inflammation through its activation of pro-caspase-1, which cleaves pro-interleukin-1β (pro-IL-1β) into its mature form and may induce acute and chronic immune responses to NPs. However, little is known about the response of the inflammasome to NP exposure via the airways in asthma. The aim of this study was to identify the impact of titanium dioxide (TiO2) NPs on inflammasome in a mouse model of allergic asthma.
Methods
Mice were treated with ovalbumin (OVA) or TiO2 NPs. IL-1β, IL-18, NAIP, CIITA, HET-E, TP-2 (NACHT), leucine-rich repeat (LRR), pyrin domain-containing protein 3 (NLRP3), and caspase-1 were assessed by Western blotting. Caspase-1 was assessed by immunohistochemistry (IHC). Levels of reactive oxygen species (ROS)—as markers of oxidative damage—and the mediators 8-isoprostane and carbonyl were measured by enzyme-linked immunosorbent assay (ELISA).
Results
Airway hyperresponsiveness (AHR) and inflammation were increased in OVA-sensitized/challenged mice, and these responses were exacerbated by exposure to TiO2 NPs. NP treatment increased IL-1β and IL-18 expression in OVA-sensitized/challenged mice. NPs augmented the expression of NLRP3 and caspase-1, leading to production of active caspase-1 in the lung. Caspase-1 expression was increased and exacerbated by TiO2 NP exposure in OVA-sensitized/challenged mice. ROS levels tended to be increased in OVA-sensitized/challenged and OVA-sensitized/challenged-plus-TiO2 NP-exposed mice.
Conclusions
Our data demonstrated that inflammasome activation occured in asthmatic lungs following NP exposure, suggesting that targeting the inflammasome may assist in controling NP-induced airway inflammation and hyperresponsiveness.
Titanium dioxideinflammasomebronchial asthmaMinistry of Environmenthttp://dx.doi.org/10.13039/5011000035622016001360009Soonchunhyang Universityhttp://dx.doi.org/10.13039/501100002560INTRODUCTION
The human respiratory tract is constantly exposed to harmful microbes and air pollutants. The immune system responds to these factors to protect the host, but an unbalanced inflammatory response can promote tissue damage and ultimately lead to acute and chronic respiratory diseases.1 Asthma is a disease of the conducting airways that involves various degrees of airflow obstruction and airway hyperresponsiveness (AHR).2 Inflammation in asthmatic lungs contributes to the pathophysiology of the disease. This occurs mostly through the release of inflammatory mediators and remodeling of the airways. Inflammation is a fundamental innate immune response to environmental factors, including air pollutants.3 Accumulating evidence indicates that the inflammasome plays a key role in the pathogenesis of acute and chronic respiratory diseases.1 The inflammasome also plays a role in chronic inflammation of the airways of patients with asthma and chronic obstructive pulmonary disease as well as in the initiation and progression of the inflammatory process in pulmonary fibrosis.4 The inflammasome is a multiprotein complex that regulates inflammation by activating specific proinflammatory cytokines, resulting in an effective host immune response.5 The innate immune system is the first line of host defense, in which the inflammasome is essential for maintaining a delicate balance between pro- and anti-inflammatory signals to generate an appropriate immune response without harming the host.5 Activation of the multiprotein complex inflammasome by danger signals plays diverse and sometimes conflicting suppressive or stimulatory roles in cancer development and progression, with marked context-dependency.3 The inflammasome is a major regulator of inflammation through its activation of pro-caspase-1, which cleaves pro-interleukin-1β (pro-IL-1β) into its mature form. IL-1β is a critical pro-inflammatory cytokine that dictates the severity of inflammation associated with a wide spectrum of inflammatory diseases. NAIP, CIITA, HET-E, TP-2 (NACHT), leucine-rich repeat (LRR) and pyrin domain-containing protein 3 (NLRP3) are key components of the inflammasome complex, and multiple signals and stimuli trigger formation of the NLRP3 inflammasome complex.6
Nanoparticles (NPs)7 are produced in many natural processes and human activities, such as those involving automobiles, industry, and charcoal burning, and they profoundly affect air quality worldwide.89 NPs are associated with asthma exacerbation and asthma immune responses.101112
To date, the role of the inflammasome in the pathogenesis of asthma-related NPs has received limited attention. In this study, we investigated the influence of NPs on the inflammasome, AHR, and inflammation in a mouse model of ovalbumin (OVA)-induced allergic lung disease.
MATERIALS AND METHODSExperimental design
Eight BALB/c mice were exposed to saline (sham) or OVA or OVA plus titanium dioxide (TiO2) NPs (50 µg/m3) (Standard Reference Material [SRM] 1898; National Institute of Standards and Technology [NIST], Gaithersburg, MD, USA) (Fig. 1) with some modifications of previous animal models.1314 After sonication, the endotoxin concentration of the diesel exhaust particle (DEP) suspension was less than 0.064 ng/mL (0.32 EU/mL), based on a Limulus Amebocyte Lysate assay (QCL-1000; BioWhittaker, Walkersville, MD, USA).15 The endotoxin concentration of the NPs was less than 0.064 ng/mL (0.32 EU/mL), based on a Limulus Amebocyte Lysate assay (QCL-1000; BioWhittaker).15 Analyses included measurement of IL-1β, IL-18, NLRP3, caspase-1, and lung protein levels as well as of bronchoalveolar lavage (BAL) fluid.
Animal exposure protocols
Female, 6-week-old BALB/c mice were sensitized by intraperitoneal (IP) injection on days 0 and 14 with 50 µg of grade V chicken egg OVA (Sigma-Aldrich, St. Louis, MO, USA) emulsified in 10 mg of hydroxyl aluminum plus 100 µL of Dulbecco's phosphate-buffered saline (D-PBS). On days 21 to 23, all mice received intranasal (IN) challenge with 150 µg of grade III OVA (Sigma-Aldrich) in 50 µL of D-PBS. Control mice were sensitized and challenged with saline. Mice in the TiO2 NP groups were administered 50 µg/m3 NPs by inhalation at 2 hours before OVA challenge daily for 3 days. On day 23, AHR was measured, BAL fluid was collected, and lung tissue was processed for protein and reactive oxygen species (ROS) measurement and Diff-Quick staining. This study was approved by the Soonchunhyang University's Institutional Animal Care and Use Committee (IRB No.; SCHBC-Animal-2014-013).
Determination of airway responsiveness to methacholine
Airway responsiveness was measured in unrestrained, conscious mice 1 day after the last challenge, as previously described.1617 Mice were placed in a barometric plethysmographic chamber (All Medicus Co., Anyang, Korea), and baseline readings were taken for 3 minutes and averaged. Increasing concentrations of aerosolized methacholine, from 2.5 to 100 mg/mL, were nebulized through an inlet of the main chamber for 3 minutes. Readings were taken for 3 minutes and averaged after each nebulization, and the enhanced pause (Penh) was determined. Penh, calculated as (expiratory time/relaxation time-1)×(peak expiratory flow/peak inspiratory flow) is a dimensionless value that represents a function of the proportion of maximal expiratory to maximal inspiratory box pressure signals and is a function of the timing of expiration. Penh was used as a measure of airway responsiveness to methacholine. Results are expressed as the percent increase in Penh following challenge with each concentration of methacholine, and baseline Penh (after saline challenge) is expressed as the actual value. Penh values were evaluated for 3 minutes after each nebulization and averaged.
BALF morphology analysis
BAL was performed 4 times using 1 mL of normal saline with gentle retrieval. Cells were counted using a hemocytometer, and differential cell counts were performed on slides prepared by cyto-centrifugation and Diff-Quik staining (Scientific Products, Gibbstown, NJ, USA).
Western blotting
Extracted lung tissue was homogenized in protein lysis solution containing 50 mM Tris-HCl (pH 7.4), 50 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 1% TritonX-100, 0.5 mM ethylenediaminetetracetic acid (EDTA), and 100 mM phenylmethylsulfonyl fluoride (PMSF) in distilled water, centrifuged at 14,000 rpm at 4℃ for 30 minutes, and the soluble material collected. Lung tissue plasma membrane protein was extracted using a MEM kit (Thermo, Rockford, IL, USA). Mouse lung proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membranes. The membranes were blocked in 5% bovine serum albumin (BSA) containing 0.1% Tween 20 in Tris-buffered saline (TBS) for 2 hours at room temperature. The membranes were then incubated with rabbit anti-NRLP3 (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-IL-18 (1:500; Santa Cruz Biotechnology), rabbit anti-IL-1β (1:1,000; Santa Cruz Biotechnology), and mouse anti-caspase-1 (1:2,000; Adipogen, San Diego, CA, USA) overnight at 4℃. Membranes were next incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies. Detection was performed using the WEST-ZOL plus the Western Blot Detection System (iNtRon, Seongnam, Korea). Relative protein abundance was determined by quantitative densitometry; data were normalized to β-actin (Sigma-Aldrich), and plasma-membrane protein levels were normalized to that of Na/K ATPase.
Immunohistochemical analysis
Mouse lung sections were deparaffinized and rehydrated in an ethanol series. The sections were treated with 1.4% H2O2 in methanol for 30 minutes to block endogenous peroxidase; they were then non-specific binding blocked using 1.5% horse serum and incubated with mouse anti-caspase-1 (1:2,000; Adipogen). The following day, sections were incubated with an ABC kit (Vector Laboratories, Burlingame, CA, USA). Color reaction was developed using a liquid DAB+ substrate kit (Golden Bridge International Inc., Mukilteo, WA, USA). After immunohistochemical staining, the slides were counterstained with Herris's hematoxylin for 1 minute. Expression was quantified using the ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Enzyme-linked immunosorbent assay (ELISA) for 8-isoprostane and carbonyl products of ROS
We indirectly measured 8-isoprostane and carbonyl levels using ELISA kits (Cell Biolabs, San Diego, CA, USA). Extracted protein from lung tissue was treated with 10 N NaOH at 45℃ for 2 hours, and then 10 N HCl was added. The samples were centrifuged for 5 minutes at 12,000 rpm in a microcentrifuge, and the clarified supernatants were assayed. Protein was derivatized using dinitrophenylhydrazine solution and incubated at room temperature in the dark. After 1 hour of incubation at room temperature on an orbital shaker, anti-dinitrophenyl (DNP) antibody was added, followed by an HRP-conjugated secondary antibody. Finally, substrate and stop solution were added. Absorbance was read using a 450-nm filter and a microplate reader. Eight-isoprostane and carbonyl levels were assayed using an OxiSelect™ competitive ELISA (Mybiosource inc., San Diego, CA, USA). Eight-isoprostane and carbonyl cutoff values of 0.2 and 10 µg/mL, respectively, were used according to the manufacturer's recommendations.
Statistical analysis
Data are expressed as means±standard error of the mean (SEM). The Mann-Whitney U test was used to determine the significance of differences between groups. Values of P<0.05 were deemed to indicate statistical significance.
RESULTS
TiO2 NP-exposed mice exhibited a greater increase in Penh compared with saline-treated mice (P<0.05, Fig. 2). OVA-exposed mice exhibited a greater increase in Penh compared with saline-treated mice, and this was exacerbated by TiO2 NP treatment (P<0.05, Fig. 2). BAL fluid showed increased total and differential cell counts in the TiO2 NP-exposed group compared with the saline-treated group. Moreover, neutrophil, eosinophil, and lymphocyte counts were increased in the TiO2 NP-exposed group compared with the saline-treated group (P<0.05, Fig. 3). The OVA-exposed group exhibited greater increases in total cell and differential cell counts compared with the saline-treated group, and these increases were exacerbated by TiO2 NP treatment (P<0.05, Fig. 3). TiO2 NP treatment increased IL-1β, IL-18, and caspase-1 protein levels, but not NLRP3 protein levels in TiO2 NP-exposed mice (P<0.05, Fig. 4). The OVA-exposed group exhibited greater IL-1β, IL-18, and NLRP3 expression levels compared with the saline-treated group, and these were exacerbated by TiO2 NP treatment (P<0.05, Fig. 4). Activated caspase-1 expression in the lungs was increased in TiO2 NP-treated mice compared with saline-treated mice (Fig. 5). The OVA-exposed group showed greater activated caspase-1 expression compared with the saline-treated group, and this was augmented by TiO2 NP treatment (Fig. 5). Caspase-1 expression was increased in the lungs of TiO2 NP-treated mice compared with saline-treated mice (Fig. 6). The OVA-exposed group showed greater activated caspase-1 expression compared with the saline-treated group, and this was augmented by TiO2 NP treatment (Fig. 6). ROS levels in the lungs tended to be increased in TiO2 NP-exposed, OVA sensitized/challenged, and OVA-sensitized/challenged-plus-TiO2 NP-exposed mice (Fig. 7).
DISCUSSION
The increased prevalence of asthma suggests that environmentally derived cofactors, such as air pollutants, are important in the development and persistence of asthma.18 The respiratory tract is continually exposed to airborne matter, which translates into frequent opportunities for interactions with mucosa-associated immunity.18 The innate immune system is the first line of host defense, and the inflammasome is essential for maintaining the delicate balance between pro- and anti-inflammatory signals to generate an appropriate immune response without harming the host.19 The innate immune response encompasses cellular and non-cellular components. The airway epithelium and mucosal layer also mediate innate immune functions beyond serving as mechanical barriers. Innate immune cells include dendritic cells, innate lymphoid cells, and leukocytes, such as macrophages, neutrophils, and eosinophils.2021 Activation of the multiprotein inflammasome by NPs plays diverse and conflicting, suppressive and stimulatory roles in the development, progression, and exacerbation of respiratory disease.22 Patients with neutrophilic asthma have augmented expression of key inflammasome components and increased release of IL-1β.23 In human airways, a functional NLRP3 inflammasome has been identified in airway epithelial cells,24 and peripheral blood neutrophils express all components of the NLRP3 inflammasome, as well as IL-1β.25 The NLRP3 inflammasome is a major component of the innate immune system, but its mechanism of activation by a wide range of molecules remains largely unknown. TiO2 NPs induce pro-inflammatory cytokine and inflammasome activation through adenosine triphosphate (ATP), adenosine diphosphate (ADP), and adenosine.262728
In this study, TiO2 NPs increased IL-1β and IL-18 levels and led to airway inflammation and AHR, suggesting that NPs initiate an innate immune response in the airway in a mouse model of asthma.
NLRP3 is a key component of the inflammasome complex, formation of which is triggered by multiple signals and stimuli.2930 In this study, expression of the components of the NLRP3 inflammasome was significantly increased in OVA exposed mice compared with control mice, suggesting that the NLRP3 inflammasome is involved in the pathogenesis of asthma. NPs induced expression of inflammasome components, leading to the formation of an active inflammasome (caspase-1 activation) in the lung. This suggests that the NLRP3 inflammasome plays a role in the host response to TiO2 NPs and is a determinant of the clinical manifestations and exacerbations of asthma. This also explains the variable pathological presentations of asthma with respect to the inflammation process of TiO2 NPs. Further studies are needed to elucidate the effect of NPs in asthmatic patients.
Diesel and automobile exhausts are the primary sources of atmospheric nano- and micro-particles in urban areas.31 Most particles from vehicle exhaust are in the size range 20-130 nm for diesel engines and 20-60 nm for gasoline engines.323334353637 The NP concentration near freeways can be high for several hundred meters, showing that vehicular pollution is a major source of local contaminant particulate matter, including NPs. Humans and their activities generate considerable quantities of particulate matter indoors.38 In this study, NP exposure was found to increase AHR and airway inflammation, indicating that NPs can induce asthma. In particular, TiO2 NPs were found to increase AHR and airway inflammation in a mouse model of allergic asthma, indicating that NPs can exacerbate the respiratory symptoms of asthmatic patients.
ROS may serve as a ‘kindling’ or triggering factor to activate NLRP3 inflammasomes, as well as ‘bonfire’ or ‘effector’ molecules, resulting in pathological processes.5 ROS, which are produced by many known activators of NLRP3 inflammasomes, trigger NLRP3 inflammasome formation and activation in response to many exogenous stimuli as well as endogenously produced molecules or factors secreted by damaged cells, such as damage-associated molecular patterns (DAMPs).3940 In this study, ROS levels tended to be increased in the lungs of mice exposed to TiO2 NPs, OVA-sensitized/challenged, and OVA-sensitized/challenged-plus-TiO2 NP-exposed mice. This suggests that NPs can increase ROS levels and lead to increased expression of IL-1β, IL-18, and inflammasome pathway proteins, causing airway inflammation and hyperresponsiveness. In our study, the signaling pathway governing inflammasome formation in the lung was found to require a priming signal to activate NLRP3 and to induce caspase-1 activation and asthma (Fig. 8). Our data demonstrated that inflammasome activation occured in the lungs of a mouse model of allergic asthma following NP exposure, suggesting that targeting the inflammasome may assist in controlling NP-induced airway inflammation.
ACKNOWLEDGMENTS
This subject was supported by the Environmental Health Action Program (2016001360009) funded from Korea Ministry of Environment (MOE) and Soonchunhyang University Research Fund.
There are no financial or other issues that might lead to conflict of interest.
BrusselleGGProvoostSBrackeKRKuchmiyALamkanfiMInflammasomes in respiratory disease: from bench to bedsideChest20141451121113324798836HolgateSTInnate and adaptive immune responses in asthmaNat Med20121867368322561831MüzesGSiposFInflammasome, inflammation and cancer: an interrelated pathobiological triadCurr Drug Targets20151624925725547909dos SantosGKutuzovMARidgeKMThe inflammasome in lung diseasesAm J Physiol Lung Cell Mol Physiol2012303L627L63322904168AbaisJMXiaMZhangYBoiniKMLiPLRedox regulation of NLRP3 inflammasomes: ROS as trigger or effector?Antioxid Redox Signal2015221111112925330206BoseSSegoviaJASomarajanSRChangTHKannanTRBasemanJBADP-ribosylation of NLRP3 by mycoplasma pneumoniae CARDS toxin regulates inflammasome activityMBio201423e02186e02114BuzeaCPachecoIIRobbieKNanomaterials and nanoparticles: sources and toxicityBiointerphases20072MR17MR7120419892TaylorDADust in the windEnviron Health Perspect2002110A80A8711836156SeeSWBalasubramanianRRisk assessment of exposure to indoor aerosols associated with Chinese cookingEnviron Res200610219720416457802EvansKAHaltermanJSHopkePKFagnanoMRichDQIncreased ultrafine particles and carbon monoxide concentrations are associated with asthma exacerbation among urban childrenEnviron Res2014129111924528997GongHJrLinnWSClarkKWAndersonKRSioutasCAlexisNEExposures of healthy and asthmatic volunteers to concentrated ambient ultrafine particles in Los AngelesInhal Toxicol20082053354518444007LiNHarkemaJRLewandowskiRPWangMBrambleLAGookinGRAmbient ultrafine particles provide a strong adjuvant effect in the secondary immune response: implication for traffic-related asthma flaresAm J Physiol Lung Cell Mol Physiol2010299L374L38320562226MoonKYParkMKLeikaufGDParkCSJangASDiesel exhaust particle-induced airway responses are augmented in obese ratsInt J Toxicol201433212824536021MoonKYLeePHKimBGParkCSLeikaufGDJangASClaudin 5 in a murine model of allergic asthma: its implication and response to steroid treatmentJ Allergy Clin Immunol201513616941696.e1-526409663GrünigGWarnockMWakilAEVenkayyaRBrombacherFRennickDMRequirement for IL-13 independently of IL-4 in experimental asthmaScience1998282226122639856950ChaMHRhimTKimKHJangASPaikYKParkCSProteomic identification of macrophage migration-inhibitory factor upon exposure to TiO2 particlesMol Cell Proteomics20076566317028300HamelmannESchwarzeJTakedaKOshibaALarsenGLIrvinCGNoninvasive measurement of airway responsiveness in allergic mice using barometric plethysmographyAm J Respir Crit Care Med19971567667759309991HuangYJThe respiratory microbiome and innate immunity in asthmaCurr Opin Pulm Med201521273225405668HallstrandTSHackettTLAltemeierWAMatute-BelloGHansbroPMKnightDAAirway epithelial regulation of pulmonary immune homeostasis and inflammationClin Immunol201415111524503171GuoHCallawayJBTingJPInflammasomes: mechanism of action, role in disease, and therapeuticsNat Med20152167768726121197MorrisABeckJMSchlossPDCampbellTBCrothersKCurtisJLComparison of the respiratory microbiome in healthy nonsmokers and smokersAm J Respir Crit Care Med20131871067107523491408PhilipNHArtisDNew friendships and old feuds: relationships between innate lymphoid cells and microbial communitiesImmunol Cell Biol20139122523123337700ShinSBrodskyIEThe inflammasome: learning from bacterial evasion strategiesSemin Immunol20152710211025914126SimpsonJLPhippsSBainesKJOreoKMGunawardhanaLGibsonPGElevated expression of the NLRP3 inflammasome in neutrophilic asthmaEur Respir J2014431067107624136334HirotaJAHirotaSAWarnerSMStefanowiczDShaheenFBeckPLThe airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matterJ Allergy Clin Immunol201212911161125.e622227418MurphyACaseyAByrneGChambersGHoweOSilver nanoparticles induce pro-inflammatory gene expression and inflammasome activation in human monocytesJ Appl Toxicol2016361311132026968431BaronLGombaultAFannyMVilleretBSavignyFGuillouNThe NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosineCell Death Dis20156e162925654762SandbergWJLågMHolmeJAFriedeBGualtieriMKruszewskiMComparison of non-crystalline silica nanoparticles in IL-1β release from macrophagesPart Fibre Toxicol201293222882971MankanAKDauTJenneDHornungVThe NLRP3/ASC/Caspase-1 axis regulates IL-1β processing in neutrophilsEur J Immunol20124271071522213227JinCFlavellRAMolecular mechanism of NLRP3 inflammasome activationJ Clin Immunol20103062863120589420KumarSVermaMKSrivastavaAKUltrafine particles in urban ambient air and their health perspectivesRev Environ Health20132811712824192498WesterdahlDFruinSSaxTFinePMSioutasCMobile platform measurements of ultrafine particles and associated pollutant concentrations on freeways and residential streets in Los AngelesAtmos Environ (1994)20053935973610SioutasCDelfinoRJSinghMExposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic researchEnviron Health Perspect200511394795516079062EvelynAMannickSSermonPAUnusual carbon-based nanofibers and chains among diesel-emitted particlesNano Lett200336364SotoKFCarrascoAPowellTGGarzaKMMurrLEComparative in vitro cytotoxicity assessment of some manufacturednanoparticulate materials characterized by transmissionelectron microscopyJ Nanopart Res20057145169KimBGLeePHLeeSHKimYEShinMYKangYLong-term effects of diesel exhaust particles on airway inflammation and remodeling in a mouse modelAllergy Asthma Immunol Res2016824625626922935SeoSKimDMinSPaulCYooYChoungJTGIS-based association between PM10 and allergic diseases in Seoul: implications for health and environmental policyAllergy Asthma Immunol Res20168324026540499AfshariAMatsonUEkbergLECharacterization of indoor sources of fine and ultrafine particles: a study conducted in a full-scale chamberIndoor Air20051514115015737157TschoppJSchroderKNLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?Nat Rev Immunol20101021021520168318GustafssonAJonassonSSandströmTLorentzenJCBuchtAGenetic variation influences immune responses in sensitive rats following exposure to TiO2 nanoparticlesToxicology2014326748525456268
Experiment protocol of TiO<sub>2</sub> NPs exposure model.
Airway responsiveness to methacholine in OVA-exposed mice group and TiO<sub>2</sub> NPs exposed mice group, and OVA plus TiO<sub>2</sub> NPs exposed mice group. <sup>*</sup><italic>P</italic><0.05 OVA, TiO<sub>2</sub> NPs vs Sham; <sup>†</sup>OVA vs OVA plus TiO<sub>2</sub> NPs.
Differential cell count in bronchoalveolar lavage fluid in OVA-exposed mice group and TiO<sub>2</sub> NPs exposed mice group, and OVA plus TiO<sub>2</sub> NPs exposed mice group. <sup>*</sup><italic>P</italic><0.05 OVA, TiO<sub>2</sub> NPs vs Sham; <sup>†</sup>OVA vs OVA plus TiO<sub>2</sub> NPs.
Lung NLRP3, IL-18, and IL1β protein levels in OVA-exposed mice group and TiO<sub>2</sub> NPs exposed mice group, and OVA plus TiO<sub>2</sub> NPs exposed mice group. <sup>*</sup><italic>P</italic><0.05 OVA, TiO<sub>2</sub> NPs vs Sham; <sup>†</sup>OVA vs OVA plus TiO<sub>2</sub> NPs.
Lung activated caspase-1 protein expression by Western blot in OVA-exposed mice group and TiO<sub>2</sub> NPs exposed mice group, and OVA plus TiO<sub>2</sub> NPs exposed mice group.
Lung caspase-1 protein expression by Hematoxylin and eosin (H&E), and immunohistochemical stain in OVA-exposed mice group and TiO<sub>2</sub> NPs exposed mice group, and OVA plus TiO<sub>2</sub> NPs exposed mice group. <sup>*</sup><italic>P</italic><0.05 OVA, TiO<sub>2</sub> NPs vs Sham; <sup>†</sup>OVA vs OVA plus TiO<sub>2</sub> NPs.
Oxidative damage markers and mediators 8-isoprotane and carbonyl lung levels by ELISA in OVA-exposed mice group and TiO<sub>2</sub> NPs exposed mice group, and OVA plus TiO<sub>2</sub> NPs exposed mice group.
TiO<sub>2</sub> NPs induced inflammasome IL-1β and IL-18-airway hyperresponsiveness and inflammation.